NCT00187551View on ClinicalTrials.gov

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
HIV Infections
Interventions
OTHER

Interruption of enfuvirtide

treatment interruption

OTHER

enfuvirtide interrupton

enfuvitide will be interrupted in patients harboring resistant virus

Trial Locations (1)

94110

San Francisco General Hospital, San Francisco

All Listed Sponsors
collaborator

Universitywide AIDS Research Program

OTHER

lead

University of California, San Francisco

OTHER

NCT00187551 - Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance | Biotech Hunter | Biotech Hunter